Oncology
ONCOLOGY Vol 37, Issue 12
Volume: 37
Issue: 12
ONCOLOGY Vol 37, Issue 11
Volume: 37
Issue: 11
ONCOLOGY Vol 37, Issue 10
Volume: 37
Issue: 10
ONCOLOGY Vol 37, Issue 9
Volume: 37
Issue: 9
ONCOLOGY Vol 37, Issue 8
Volume: 37
Issue: 8
ONCOLOGY Vol 37, Issue 7
Volume: 37
Issue: 7
ONCOLOGY Vol 37, Issue 6
Volume: 37
Issue: 6
ONCOLOGY Vol 37, Issue 5
Volume: 37
Issue: 5
ONCOLOGY Vol 37, Issue 4
Volume: 37
Issue: 4
ONCOLOGY Vol 37, Issue 3
Volume: 37
Issue: 3
ONCOLOGY Vol 37, Issue 2
Volume: 37
Issue: 2
ONCOLOGY Vol 37, Issue 1
Volume: 37
Issue: 1
ONCOLOGY Vol 36, Issue 12
Volume: 36
Issue: 12
ONCOLOGY Vol 36, Issue 11
Volume: 36
Issue: 11
ONCOLOGY Vol 36, Issue 10
Volume: 36
Issue: 10
ONCOLOGY Vol 36, Issue 9
Volume: 36
Issue: 9
ONCOLOGY Vol 36, Issue 8
Volume: 36
Issue: 8
ONCOLOGY Vol 36, Issue 7
Volume: 36
Issue: 7
ONCOLOGY Vol 36, Issue 6
Volume: 36
Issue: 6
ONCOLOGY Vol 36, Issue 5
Volume: 36
Issue: 5
ONCOLOGY Vol 36, Issue 4
Volume: 36
Issue: 4
ONCOLOGY Vol 36, Issue 3
Volume: 36
Issue: 3
ONCOLOGY Vol 36, Issue 2
Volume: 36
Issue: 2
ONCOLOGY Vol 36, Issue 1
Volume: 36
Issue: 2
ONCOLOGY Vol 35, Issue 12
ONCOLOGY Vol 35, Issue 11
Volume: 35
Issue: 11
ONCOLOGY Vol 35, Issue 10
ONCOLOGY Vol 35, Issue 9
ONCOLOGY Vol 35, Issue 8
ONCOLOGY Vol 35, Issue 7
Volume: 35
Issue: 7
Advertisement
Advertisement
Trending on CancerNetwork
1
Isatuximab-Based Therapy Shows “Impressive” PFS Projections in NDMM
2
CELMoD-Based Maintenance Deepens Responses After ASCT in Multiple Myeloma
3
Durvalumab Plus Enfortumab Vedotin Earns FDA Priority Review in MIBC
4
Subcutaneous Isatuximab Enhances Patient Experience in Multiple Myeloma
5